Irish Stephanie Rast 4
4 · Vanda Pharmaceuticals Inc. · Filed May 13, 2009
Insider Transaction Report
Form 4
Irish Stephanie Rast
Sr. VP, Acting CFO/Treasurer
Transactions
- Sale
Common Stock
2009-05-13$12.00/sh−10,000$120,000→ 2,449 total - Exercise/Conversion
Restricted Stock Units
2009-05-11−20,000→ 0 total→ Common Stock (20,000 underlying) - Exercise/Conversion
Common Stock
2009-05-11+20,000→ 20,000 total - Sale
Common Stock
2009-05-12$10.11/sh−7,551$76,347→ 12,449 total
Footnotes (2)
- [F1]The Restricted Stock Units represented a contingent right to receive a share of the Issuer's common stock which vested upon the Issuer's receipt of approval by the United States Food & Drug Administration of its New Drug Application for Fanapt(TM) (iloperidone) on May 6, 2009.
- [F2]N/A